Paul Matteis' Stock Ratings

Stifel Analyst

Paul Matteis is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

-0.30%

Smart Score

50.8%

Overall Average Return Percentile

35th

Number of Ratings

47
Buy NowGet Alert
05/09/2024ACADBuy Now
ACADIA Pharmaceuticals
$15.1538.61%$26 → $21MaintainsHoldGet Alert
04/30/2024CTNMBuy Now
Contineum Therapeutics
$15.0193.2% → $29Initiates → BuyGet Alert
03/25/2024ANROBuy Now
Alto Neuroscience
$12.40158.06% → $32ReiteratesBuy → BuyGet Alert
03/06/2024DYNBuy Now
Dyne Therapeutics
$35.5015.49%$35 → $41MaintainsBuyGet Alert
02/27/2024ANROBuy Now
Alto Neuroscience
$12.40158.06% → $32Initiates → BuyGet Alert
01/05/2024NGNEBuy Now
Neurogene
$34.01-8.85% → $31Initiates → BuyGet Alert
12/21/2023BMRNBuy Now
Biomarin Pharmaceutical
$77.0531.08% → $101ReiteratesBuy → BuyGet Alert
12/18/2023SAGEBuy Now
Sage Therapeutics
$11.2577.78%$22 → $20MaintainsHoldGet Alert
12/18/2023NBIXBuy Now
Neurocrine Biosciences
$141.651.66%$141 → $144MaintainsBuyGet Alert
12/18/2023IONSBuy Now
Ionis Pharmaceuticals
$38.7229.13%$45 → $50MaintainsHoldGet Alert
12/18/2023ACADBuy Now
ACADIA Pharmaceuticals
$15.1578.22%$25 → $27MaintainsHoldGet Alert
12/14/2023BIIBBuy Now
Biogen
$231.5823.93%$315 → $287MaintainsBuyGet Alert
12/14/2023ALECBuy Now
Alector
$5.50172.73%$8 → $15UpgradeHold → BuyGet Alert
11/28/2023LXEOBuy Now
Lexeo Therapeutics
$13.8544.4% → $20Initiates → BuyGet Alert
11/22/2023VRTXBuy Now
Vertex Pharmaceuticals
$445.87-16.34% → $373ReiteratesHold → HoldGet Alert
11/14/2023VTGNBuy Now
Vistagen Therapeutics
$4.53164.9% → $12Initiates → BuyGet Alert
11/07/2023VRTXBuy Now
Vertex Pharmaceuticals
$445.87-16.34%$340 → $373MaintainsHoldGet Alert
10/10/2023NMRABuy Now
Neumora Therapeutics
$9.69168.32% → $26Initiates → BuyGet Alert
09/14/2023ALNYBuy Now
Alnylam Pharmaceuticals
$148.0462.12% → $240ReiteratesBuy → BuyGet Alert
08/08/2023ALECBuy Now
Alector
$5.5045.45%$10 → $8MaintainsHoldGet Alert
08/07/2023SAGEBuy Now
Sage Therapeutics
$11.2595.56%$60 → $22DowngradeBuy → HoldGet Alert
08/01/2023BMRNBuy Now
Biomarin Pharmaceutical
$77.0540.17%$118 → $108MaintainsBuyGet Alert
07/25/2023BIIBBuy Now
Biogen
$231.5838.18%$324 → $320MaintainsBuyGet Alert
06/14/2023PEPGBuy Now
PepGen
$13.4977.91% → $24ReiteratesBuy → BuyGet Alert
06/06/2023ALKSBuy Now
Alkermes
$24.3835.36%$31 → $33MaintainsHoldGet Alert
06/06/2023NBIXBuy Now
Neurocrine Biosciences
$141.65-11.75%$145 → $125MaintainsBuyGet Alert
05/02/2023VRTXBuy Now
Vertex Pharmaceuticals
$445.87-23.74%$300 → $340MaintainsHoldGet Alert
02/28/2023BMRNBuy Now
Biomarin Pharmaceutical
$77.0553.15%$114 → $118MaintainsBuyGet Alert
02/09/2023VRTXBuy Now
Vertex Pharmaceuticals
$445.87-32.72%$289 → $300MaintainsHoldGet Alert
10/30/2022VRTXBuy Now
Vertex Pharmaceuticals
$445.87-35.18% → $289MaintainsHoldGet Alert